Literature DB >> 12791527

Tobacco-specific nitrosamines in tobacco from U.S. brand and non-U.S. brand cigarettes.

David L Ashley1, Michelle D Beeson, Diana R Johnson, Joan M McCraw, Patricia Richter, James L Pirkle, Terry F Pechacek, Siqing Song, Clifford H Watson.   

Abstract

Tobacco-specific nitrosamines (TSNAs) are one of the major classes of carcinogens found in tobacco products. As part of collaborative efforts to reduce tobacco use and resulting disease, the U.S. Centers for Disease Control and Prevention (CDC) carried out a two-phase investigation into the worldwide variation of the levels of TSNAs in cigarette tobacco. In the first phase, representatives of the World Health Organization (WHO) purchased cigarettes; scientists from the CDC subsequently measured the levels of TSNAs in tobacco from 21 different countries. Although the data collected from this initial survey suggested that globally marketed U.S.-brand cigarettes typically had higher TSNA levels than locally popular non-U.S. cigarettes in many countries, the number of samples limited the statistical power of the study. To improve statistical power and to ensure adequate sampling, the CDC conducted a second survey of 14 countries. In addition to the United States, the CDC selected the world's 10 most populous countries and three additional countries, so that at least two countries from each of the six WHO regions were represented. For each country, the CDC compared 15 packs of Marlboro cigarettes, which is the world's most popular brand of cigarettes, with 15 packs of a locally popular non-U.S. brand in the study country. Marlboro cigarettes purchased in 11/13 foreign countries had significantly higher tobacco TSNA levels than the locally popular non-U.S. brands purchased in the same country. The findings suggest that TSNA levels in tobacco can be substantially reduced in some cigarettes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12791527     DOI: 10.1080/1462220031000095311

Source DB:  PubMed          Journal:  Nicotine Tob Res        ISSN: 1462-2203            Impact factor:   4.244


  14 in total

1.  Effect of differing levels of tobacco-specific nitrosamines in cigarette smoke on the levels of biomarkers in smokers.

Authors:  David L Ashley; Richard J O'Connor; John T Bernert; Clifford H Watson; Gregory M Polzin; Ram B Jain; David Hammond; Dorothy K Hatsukami; Gary A Giovino; K Michael Cummings; Ann McNeill; Lion Shahab; Bill King; Geoffrey T Fong; Liqin Zhang; Yang Xia; Xizheng Yan; Joan M McCraw
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-05-25       Impact factor: 4.254

2.  Carcinogenic tobacco-specific N-nitrosamines in US cigarettes: three decades of remarkable neglect by the tobacco industry.

Authors:  Irina Stepanov; Aleksandar Knezevich; Liqin Zhang; Clifford H Watson; Dorothy K Hatsukami; Stephen S Hecht
Journal:  Tob Control       Date:  2011-05-20       Impact factor: 7.552

3.  Tobacco-Specific Nitrosamines in the Tobacco and Mainstream Smoke of U.S. Commercial Cigarettes.

Authors:  Selvin H Edwards; Lana M Rossiter; Kenneth M Taylor; Matthew R Holman; Liqin Zhang; Yan S Ding; Clifford H Watson
Journal:  Chem Res Toxicol       Date:  2016-12-21       Impact factor: 3.739

Review 4.  Toward a comprehensive long term nicotine policy.

Authors:  N Gray; J E Henningfield; N L Benowitz; G N Connolly; C Dresler; K Fagerstrom; M J Jarvis; P Boyle
Journal:  Tob Control       Date:  2005-06       Impact factor: 7.552

5.  Different profiles of carcinogen exposure in Chinese compared with US cigarette smokers.

Authors:  Neal L Benowitz; Quan Gan; Maciej L Goniewicz; Wei Lu; Jiying Xu; Xinjian Li; Peyton Jacob; Stanton Glantz
Journal:  Tob Control       Date:  2014-12-22       Impact factor: 7.552

6.  Urine cotinine underestimates exposure to the tobacco-derived lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in passive compared with active smokers.

Authors:  Neal Benowitz; Maciej Lukasz Goniewicz; Mark D Eisner; Eduardo Lazcano-Ponce; Wioleta Zielinska-Danch; Bartosz Koszowski; Andrzej Sobczak; Christopher Havel; Peyton Jacob
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-08-30       Impact factor: 4.254

7.  It is time to regulate carcinogenic tobacco-specific nitrosamines in cigarette tobacco.

Authors:  Stephen S Hecht
Journal:  Cancer Prev Res (Phila)       Date:  2014-05-07

8.  Mainstream Smoke Levels of Volatile Organic Compounds in 50 U.S. Domestic Cigarette Brands Smoked With the ISO and Canadian Intense Protocols.

Authors:  Daniel Y Pazo; Fallon Moliere; Maureen M Sampson; Christopher M Reese; Kimberly A Agnew-Heard; Matthew J Walters; Matthew R Holman; Benjamin C Blount; Clifford H Watson; David M Chambers
Journal:  Nicotine Tob Res       Date:  2016-04-25       Impact factor: 4.244

9.  The Strategic Dialogue on Tobacco Harm Reduction: a vision and blueprint for action in the US.

Authors:  Mitchell Zeller; Dorothy Hatsukami
Journal:  Tob Control       Date:  2009-02-24       Impact factor: 7.552

10.  Tobacco-specific nitrosamine exposures in smokers and nonsmokers exposed to cigarette or waterpipe tobacco smoke.

Authors:  Ghada Radwan; Stephen S Hecht; Steven G Carmella; Christopher A Loffredo
Journal:  Nicotine Tob Res       Date:  2012-05-09       Impact factor: 4.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.